NCT01526928 · Interventional trial
Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Locally Advanced or Metastatic Non Small Cell Lung Cancer
Delaware Valley sites
- Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory